William H Herman
What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?. J Diabetes Complicat 2018; 32:911-915.
12.06.2018What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
12.06.2018J Diabetes Complicat 2018; 32:911-915
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC). J Diabetes Complicat 2018; 32:934-939.
12.06.2018The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
12.06.2018J Diabetes Complicat 2018; 32:934-939
Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
Palmer A, Gahn J, Valentine W, Pollock R, Breeze P, Brennan A, Pollard D, Ye W, Herman W, Isaman D, Kuo S, Laiteerapong N, Tran-Duy A, Smolen H, Brändle M, Si L, Tew M, Hua X, Willis M, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor P, Clarke P. Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value Health 2018; 21:724-731.
09.04.2018Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
09.04.2018Value Health 2018; 21:724-731
Palmer Andrew J, Gahn James C, Valentine William J, Pollock Richard F, Breeze Penny, Brennan Alan, Pollard Daniel, Ye Wen, Herman William H, Isaman Deanna J, Kuo Shihchen, Laiteerapong Neda, Tran-Duy An, Smolen Harry J, Brändle Michael, Si Lei, Tew Michelle, Hua Xinyang, Willis Michael S, Asseburg Christian, McEwan Phil, Leal José, Gray Alastair, Foos Volker, Lamotte Mark, Feenstra Talitha, O'Connor Patrick J, Clarke Philip M
The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation
Ye W, Brändle M, Brown M, Herman W. The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation. Diabetes Technol Ther 2015; 17:701-11.
29.07.2015The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation
29.07.2015Diabetes Technol Ther 2015; 17:701-11
Ye Wen, Brändle Michael, Brown Morton B, Herman William H
Managing people at high risk for diabetes
Herman W, Ackermann R, Marrero D, Hamman R, Engelgau M, Zhang P, Sorensen S, Brändle M, Hicks K, Hoerger T, Ratner R. Managing people at high risk for diabetes. Annals of internal medicine 2006; 144:66-7; author reply 67-8.
03.01.2006Managing people at high risk for diabetes
03.01.2006Annals of internal medicine 2006; 144:66-7; author reply 67-8
Herman William H, Ackermann Ronald T, Marrero David G, Hamman Richard F, Engelgau Michael M, Zhang Ping, Sorensen Stephen W, Brändle Michael, Hicks Katherine, Hoerger Thomas J, Ratner Robert E
A computer simulation model of diabetes progression, quality of life, and cost
Zhou H, Isaman D, Messinger S, Brown M, Klein R, Brändle M, Herman W. A computer simulation model of diabetes progression, quality of life, and cost. Diabetes care 2005; 28:2856-63.
01.12.2005A computer simulation model of diabetes progression, quality of life, and cost
01.12.2005Diabetes care 2005; 28:2856-63
Zhou Honghong, Isaman Deanna J M, Messinger Shari, Brown Morton B, Klein Ronald, Brändle Michael, Herman William H
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
Herman W, Ratner R, Engelgau M, Ackermann R, Hamman R, Zhang P, Sorensen S, Hicks K, Brändle M, Hoerger T, Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Annals of internal medicine 2005; 142:323-32.
01.03.2005The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
01.03.2005Annals of internal medicine 2005; 142:323-32
Herman William H, Ratner Robert E, Engelgau Michael M, Ackermann Ronald T, Hamman Richard F, Zhang Ping, Sorensen Stephen, Hicks Katherine, Brändle Michael, Hoerger Thomas J, Diabetes Prevention Program Research Group
The CORE Diabetes Model
Brändle M, Herman W. The CORE Diabetes Model. Current medical research and opinion 2004; 20 Suppl 1:S1-3.
01.08.2004The CORE Diabetes Model
01.08.2004Current medical research and opinion 2004; 20 Suppl 1:S1-3
Brändle Michael, Herman William H
Opportunistic screening for diabetes in routine clinical practice
Ealovega M, Tabaei B, Brändle M, Burke R, Herman W. Opportunistic screening for diabetes in routine clinical practice. Diabetes care 2004; 27:9-12.
01.01.2004Opportunistic screening for diabetes in routine clinical practice
01.01.2004Diabetes care 2004; 27:9-12
Ealovega Mark W, Tabaei Bahman P, Brändle Michael, Burke Ray, Herman William H
The direct medical cost of type 2 diabetes
Brändle M, Zhou H, Smith B, Marriott D, Burke R, Tabaei B, Brown M, Herman W. The direct medical cost of type 2 diabetes. Diabetes care 2003; 26:2300-4.
01.08.2003The direct medical cost of type 2 diabetes
01.08.2003Diabetes care 2003; 26:2300-4
Brändle Michael, Zhou Honghong, Smith Barbara R K, Marriott Deanna, Burke Ray, Tabaei Bahman P, Brown Morton B, Herman William H
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
Brändle M, Davidson M, Schriger D, Lorber B, Herman W. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes care 2003; 26:1796-801.
01.06.2003Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
01.06.2003Diabetes care 2003; 26:1796-801
Brändle Michael, Davidson Mayer B, Schriger David L, Lorber Brett, Herman William H
Valuing health-related quality of life in diabetes
Coffey J, Brändle M, Zhou H, Marriott D, Burke R, Tabaei B, Engelgau M, Kaplan R, Herman W. Valuing health-related quality of life in diabetes. Diabetes care 2002; 25:2238-43.
01.12.2002Valuing health-related quality of life in diabetes
01.12.2002Diabetes care 2002; 25:2238-43
Coffey J Todd, Brändle Michael, Zhou Honghong, Marriott Deanna, Burke Ray, Tabaei Bahman P, Engelgau Michael M, Kaplan Robert M, Herman William H